MedTrace Logo

Optimising Management of Patients With Heart Failure With Preserved Ejection Fraction in Primary Care

NCT03617848 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2022-02-15

No results posted yet for this study

Summary

Heart failure (HF) accounts for 2% of National Health Service (NHS) expenditure, and 5% of emergency hospitalisations. Patients with HF with preserved ejection fraction (HFpEF) are older, have more comorbidities, have similarly poor or worse outcomes compared to patients with reduced ejection fraction (HFrEF), and currently lack an evidence base for treatment. The investigators hypothesise that outcomes of patients with HFpEF can be improved through optimised management and self-management of comorbidities, fluid status and lifestyle delivered in primary care in collaboration with specialists. The primary aim is to develop a programme of optimised management by improving understanding of needs and experiences of patients with HFpEF, clinical decision-making and management in primary care, and integrating research findings with patient and clinical expertise. The main objective for this work package is to identify patients with HFpEF in primary care and assess comorbidities and other factors, management, morbidity and mortality at one year. The methodology employed will be a longitudinal cohort study of 270 patients with HFpEF in primary care followed for 12 months.

Conditions

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Keele University

    collaborator OTHER

  • University of Manchester

    collaborator OTHER

  • Professor Christi Deaton

    lead OTHER

Principal Investigators

  • Christi Deaton, PhD,RN · Cambridge University Hospitals NHS FT

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-17
Primary Completion
2020-11-30
Completion
2021-03-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03617848 on ClinicalTrials.gov